Published in J Chromatogr B Biomed Appl on October 25, 1996
PARP inhibitor treatment in ovarian and breast cancer. Curr Probl Cancer (2011) 1.08
Transformation and removal pathways of four common PPCP/EDCs in soil. Environ Pollut (2014) 0.77
The chemistry and kinetics of Lioresal. Postgrad Med J (1972) 1.29
Biotransformation and pharmacokinetics of acenocoumarol (Sintrom) in man. Eur J Clin Pharmacol (1977) 1.22
Pharmacokinetics and metabolism of the anti-inflammatory agent Voltaren. Scand J Rheumatol Suppl (1978) 1.12
Synthesis and quantitative structure-activity relationships of diclofenac analogues. J Med Chem (1990) 1.00
Metabolism of niridazole in various species, including man. Ann N Y Acad Sci (1969) 0.99
The metabolism of 14C-oxcarbazepine in man. Xenobiotica (1986) 0.99
Biotransformation and pharmacokinetics of sulfinpyrazone (Anturan) in man. Eur J Clin Pharmacol (1975) 0.96
Pharmacological properties of diclofenac sodium and its metabolites. Scand J Rheumatol Suppl (1978) 0.95
Biotransformation of diclofenac sodium (Voltaren) in animals and in man. I. Isolation and identification of principal metabolites. Xenobiotica (1979) 0.91
Biotransformation of diclofenac sodium (Voltaren) in animals and in man. II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile. Xenobiotica (1979) 0.91
Selective uptake of an antibilharzial nitrothiazole compound by Schistosoma mansoni. Nature (1966) 0.83
Sodium (o-((2,6-dichlorophenyl)-amino)-phenyl)-acetate (GP 45 840), a new non-steroidal anti-inflammatory agent. Experientia (1973) 0.81
The biotransformation of phenylbutazone (Butazolidin). J Int Med Res (1977) 0.79
C-glucuronides, a novel type of drug metabolites. Helv Chim Acta (1975) 0.79
Pharmacokinetics and metabolism of formestane in breast cancer patients. J Steroid Biochem Mol Biol (2001) 0.79
The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose. Xenobiotica (1991) 0.79
New metabolites of sulfinpyrazone in man. Arzneimittelforschung (1980) 0.79
Metabolism of hydralazine in man. Arzneimittelforschung (1977) 0.78
Single-dose kinetics of an enteric-coated formulation of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine. Ther Drug Monit (1988) 0.78
Disposition and pharmacokinetics of cadralazine and individual metabolites in man. Eur J Drug Metab Pharmacokinet (1985) 0.78
Strategies in the design of peptidoleukotriene antagonists. J Lipid Mediat (1993) 0.78
Rapid characterization of artemether and its in vitro metabolites on incubation with bovine hemoglobin, rat blood and dog blood by capillary gas chromatography-chemical ionization mass spectrometry. J Chromatogr B Biomed Sci Appl (1998) 0.78
Pharmacological properties of five diclofenac metabolites identified in human plasma. Agents Actions (1991) 0.78
[On the penetration of foreign body materials into the young vertebrate embryo]. Bull Schweiz Akad Med Wiss (1966) 0.76
Blood levels of a schistosomicide in relation to liver function and side effects. Acta Pharmacol Toxicol (Copenh) (1971) 0.76
Haemodialysis in imipramine poisoning? An experimental study. Klin Wochenschr (1976) 0.75
The disposition and metabolism of 14C-oxprenolol.HCl in man. Xenobiotica (1986) 0.75
The chemistry of diclofenac sodium (Voltarol). Rheumatol Rehabil (1979) 0.75
Tricyclic drugs: potent mutagenicity of traces of a nitroarene formed in the reaction of opipramol with nitrite. Mutat Res (1987) 0.75
The metabolic fate of [14C]oxaprotiline.HCl in man. II. Isolation and identification of metabolites. Xenobiotica (1984) 0.75
The metabolism of niridazole (AMBILHARR) in man. II. Investigations on patients suffering from clinically advanced forms of Schistosoma mansoni infection. Ann Trop Med Parasitol (1970) 0.75
Multiple inverse isotope dilution assay for oxprenolol and nine metabolites in biological fluids. J Chromatogr (1983) 0.75
The metabolic fate of [14C]oxaprotiline.HCl in man. I. Disposition and preliminary pharmacokinetics. Xenobiotica (1984) 0.75
Indoxyl derivatives of drug metabolites. Experientia (1985) 0.75
CGP 35949: a potent leukotriene antagonist and inhibitor of phospholipase. Biological profile. Adv Prostaglandin Thromboxane Leukot Res (1987) 0.75
Multiple inverse isotope dilution assay for the stereospecific quantitative determination of R(-) and S(+)-oxaprotiline in biological fluids. J Chromatogr (1982) 0.75
Biotransformation of oxaprotiline: isolation and identification of metabolites in urine of rat and dog. Xenobiotica (1986) 0.75
Species differences in the disposition and metabolism of sulfinpyrazone. Xenobiotica (1981) 0.75
Pharmacokinetics of diclofenac sodium (Voltaren) and metabolites in patients with impaired renal function. Scand J Rheumatol Suppl (1978) 0.75
The metabolic fate of 14C-oxaprotiline X HCl in man. III. Stereospecific disposition. Biopharm Drug Dispos (1985) 0.75
Metabolism of phenylbutazone in man. Arzneimittelforschung (1976) 0.75
The metabolism of niridazole (AMBILHARR) in man. I. Investigations on patients suffering from clinically mild forms of Schistosoma haematobium and Schistosoma mansoni infection. Ann Trop Med Parasitol (1970) 0.75
Multiple inverse isotope dilution assay for cadralazine and four metabolites in biological fluids. J Chromatogr (1983) 0.75
CGP 35949, an LTD4 antagonist with phospholipase inhibitory activity: a new approach to the treatment of asthma. Adv Prostaglandin Thromboxane Leukot Res (1987) 0.75
The metabolic fate of Ciba 32644-Ba. Acta Trop Suppl (1966) 0.75
Isolation and stereospecific determination of the enantiomers of oxindazac by direct liquid chromatographic resolution on triacetylcellulose. J Chromatogr (1985) 0.75
Multiple inverse isotope dilution assay for the stereospecific determination of R(+)- and S(-)-oxprenolol in biological fluids. J Chromatogr (1983) 0.75
Letter: Reserpine and chemical carcinogenesis. Lancet (1975) 0.75